Remove roche-having-shared-data-regulators-unwraps-results-subcutaneous-tecentriq-phase-3-trial
article thumbnail

Roche, having shared data with regulators, unwraps results of subcutaneous Tecentriq phase 3 trial

Fierce Pharma

Roche, having shared data with regulators, unwraps results of subcutaneous Tecentriq phase 3 trial. Thu, 12/01/2022 - 09:45.

258
258